Elevated serum levels of S100 and survival in metastatic malignant melanoma

British Journal of Cancer

Volumn 75, Issue 9, 1997, Pages 1373-1376

  Buer, J ^a   Probst, M ^a   Franzke, A ^a   Duensing, S ^a   Haindl, J ^a   Volkenandt, M ^b   Wittke, F ^a   Hoffmann, R ^a   Ganser, A ^a   Atzpodien, J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Metastatic malignant melanoma; Multivariate analysis of survival; Prognosis; S100

Indexed keywords

PROTEIN S 100;

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 8244260614     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.232     Document Type: Article

References (19)

1. Atzpodien J, Lopez Hänninen E, Kirchner H, Franzke A, Körfer A, Volkenandt M, Duensing S, Schomburg A, Chaitchik S and Poliwoda H (1445) Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous Interleukin-2 and Interferon-α after intravenous dacarbazine, cisplatin, carmustine and Tamoxifen. Eur J Cancer 31A: 876-881
2. Cox DR (1972) Regression models and life-tables. J R Stat Soc [B] 34: 187-220
3. Dannies PS and Levine L (1969) Demonstration of subunits of beef brain acidic protein S-100. Biochem Biophys Res Commun 37: 587-542
4. Fagnart OC, Sindic CJM and Laterre C (1988) Particle counting immunoassay of S-100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 34: 1387-1391
5. Gaynor R, Herschman HR, Irie R, Jones P, Morton D and Cochran A (1981) S100 protein: a marker for human malignant melanomas? Lancet 1: 869-871
6. Glass AG and Hoover RN (1993) The emerging epidemic of melanoma and squamous cell cancer. J Am Med Assoc 262: 2097-2100
7. Grin-Jorgensen CM, Rigel DS and Friedman RJ (1992) The worldwide incidence of malignant melanoma. In Cutaneous Melanoma, Balch MB, Houghton AN, Milton GW, Sober AJ and Soong SJ (eds). pp. 27-39. JB Lippincott: Philadelphia
8. Guo HB, Stoffel-Wagner B, Bierwirth T, Mezger J and Klingmüller D (1995) Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer 31A: 1898-1902
9. Heimdal K, Hannisdal E and Gunderson S (1989) Metastatic malignant melanoma. Eur J Cancer 25: 1219-1223
10. Isobe T, Ishioka N and Okuyama T (1981) Structural relation of two S-100 proteins in bovine brain; subunit composition of S100a protein. Eur J Biochem 115: 469-174
11. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
12. Karlsson M, Jungnelius U, Aamdal S, Boeryd B, Carstensen J and Kägedal B (1996) Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma. Int J Cancer 65: 1-5
13. Koh HK (1991) Cutaneous melanoma. N Engl J Med 325: 171-182
14. Kunler U, Buer J, Probst M, Duensing S, Dallmann I, Grosse J, Kirchner H, Schluepen EV, Volkenandt M, Ganser A and Atzpodien J (1996) Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 88: 590-594
15. Legha SS (1989) Current therapy for malignant melanoma. Sem Oncol 16: 34-44
16. Sirott MN, Bajorin DF, Wong GYN, Tao Y, Chapman PB, Templelon MA and Houghton AN (1993) Prognostic factors in patients with metastatic malignant melanoma. Cancer 72: 3091-3098
17. Smith H, Selby P, Southgate J, Pittman K, Bradley C and Blair GF (1991) Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227-1279
18. Trent JM, Meyskens FL, Salmon SE, Ryschon K, Leong SPL, Davis JR and McGee DL (1990) Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma. N Engl J Med 322: 1508-1511
19. Xerri L, Grob JJ, Battyani Z, Gouvernet J, Hassoun J and Bonerandi JJ (1994) NM23 expression in metastasis of malignant melanoma is predictive prognostic parameter correlated with survival. Br J Cancer 70: 1224-1228